ExodusPoint Capital Management LP Takes Position in Oscar Health, Inc. (NYSE:OSCR)

ExodusPoint Capital Management LP purchased a new position in shares of Oscar Health, Inc. (NYSE:OSCRFree Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 190,150 shares of the company’s stock, valued at approximately $2,556,000. ExodusPoint Capital Management LP owned about 0.08% of Oscar Health as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. State Street Corp lifted its position in shares of Oscar Health by 6.0% during the third quarter. State Street Corp now owns 5,132,802 shares of the company’s stock worth $108,867,000 after purchasing an additional 291,335 shares during the last quarter. Lingotto Investment Management LLP purchased a new stake in Oscar Health in the 4th quarter valued at about $2,543,000. GDS Wealth Management boosted its position in Oscar Health by 1,545.3% in the 4th quarter. GDS Wealth Management now owns 345,817 shares of the company’s stock valued at $4,648,000 after buying an additional 324,798 shares during the period. Victory Capital Management Inc. grew its stake in Oscar Health by 296.0% in the 4th quarter. Victory Capital Management Inc. now owns 231,059 shares of the company’s stock worth $3,105,000 after acquiring an additional 172,706 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Oscar Health during the fourth quarter worth approximately $5,672,000. 75.70% of the stock is owned by institutional investors.

Oscar Health Stock Down 3.8 %

Oscar Health stock opened at $12.51 on Tuesday. Oscar Health, Inc. has a twelve month low of $11.89 and a twelve month high of $23.79. The business has a fifty day moving average of $14.53 and a two-hundred day moving average of $15.68. The firm has a market cap of $3.13 billion, a P/E ratio of -624.94 and a beta of 1.75. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCRGet Free Report) last issued its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. On average, analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently issued reports on OSCR shares. Jefferies Financial Group began coverage on Oscar Health in a research note on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price objective on the stock. Wells Fargo & Company downgraded Oscar Health from an “overweight” rating to an “equal weight” rating and dropped their price target for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, three have given a hold rating, two have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $20.21.

Read Our Latest Stock Analysis on Oscar Health

About Oscar Health

(Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Further Reading

Institutional Ownership by Quarter for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.